Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer

Colorectal Disease

Volumn 15, Issue 10, 2013, Pages e582-e591

  Van der Geest, L G M ^a   Portielje, J E A ^b   Wouters, M W J M ^c   Weijl, N I ^d   Tanis, B C ^e   Tollenaar, R A E M ^c   Struikmans, H ^f   Nortier, J W R ^c  

^a Department of Research   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e GROENE HART HOSPITAL   (Netherlands)

^f Radiotherapy Centre West   (Netherlands)

Author keywords

Adjuvant chemotherapy; Colon cancer; Delay; Discontinuation; Postoperative recovery; Stage III

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; COLON CANCER; EMERGENCY SURGERY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NETHERLANDS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SKIN TOXICITY; THERAPY DELAY; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT;

ADJUVANT CHEMOTHERAPY; COLON CANCER; DELAY; DISCONTINUATION; POSTOPERATIVE RECOVERY; STAGE III;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMORBIDITY; EMERGENCIES; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; REOPERATION; SEX FACTORS; SOCIAL CLASS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 84886291469     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12288     Document Type: Article

References (29)

1. Brenner H, Bouvier AM, Foschi R et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer 2012; 131: 1649-58.
2. van Steenbergen LN, Elferink MA, Krijnen P et al. Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol 2010; 21: 2206-12.
3. Gatta G, Zigon G, Aareleid T et al. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study. Acta Oncol 2010; 49: 776-83.
4. Etzioni DA, El-Khoueiry AB, Beart RW Jr. Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review. Cancer 2008; 113: 3279-89.
5. Hendren S, Birkmeyer JD, Yin H, Banerjee M, Sonnenday C, Morris AM. Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer. Dis Colon Rectum 2010; 53: 1587-93.
6. Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 2011; 305: 2335-42.
7. Neugut AI, Matasar M, Wang X et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 2006; 24: 2368-75.
8. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22: 369-76.
9. Fritz A, Percy C, Jack A et al. (eds. 2000 3rd edition) International Classification of Diseases for Oncology (ICD-O). World Health Organization, Geneva.
10. Wittekind C, Greene F, Hutter R, Klimpfinger M, Sobin L (eds.). (2004). TNM atlas. Springer-Verlag, Berlin.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
12. Cheung WY, Neville BA, Earle CC. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum 2009; 52: 1054-63. discussion 1064.
13. Comprehensive Cancer Centre the Netherlands (CCCNL). National Evidence Based Guideline For Colon Cancer 2008. Available at: http://www.oncoline.nl/coloncarcinoom (accessed December 5 2011).
14. Chau I, Cunningham D. Adjuvant therapy in colon cancer-what, when and how? Ann Oncol 2006; 17: 1347-59.
15. Ahmed S, Ahmad I, Zhu T et al. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study. Dis Colon Rectum 2010; 53: 1432-8.
16. Hershman D, Hall MJ, Wang X et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 2006; 107: 2581-8.
17. Khoury W, Lavery IC, Kiran RP. Impact of early reoperation after resection for colorectal cancer on long-term oncological outcomes. Colorectal Dis 2012; 14: e117-23.
18. Aslani N, Lobo-Prabhu K, Heidary B, Phang T, Raval MJ, Brown CJ. Outcomes of laparoscopic colon cancer surgery in a population-based cohort in British Columbia: are they as good as the clinical trials? Am J Surg 2012; 204: 411-5.
19. Robinson CN, Chen GJ, Balentine CJ et al. Minimally invasive surgery is underutilized for colon cancer. Ann Surg Oncol 2011; 18: 1412-8.
20. Bottino V, Esposito MG, Mottola A et al. Early outcomes of colon laparoscopic resection in the elderly patients compared with the younger. BMC Surg. 2012; 12 (Suppl 1): S8. doi: 10.1186/1471-2482-12-S1-S8.
21. Schwenk W, Haase O, Neudecker J, Muller JM. Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev. 2005; (3): CD003145.
22. Lacy AM, Garcia-Valdecasas JC, Delgado S et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002; 359: 2224-9.
23. Bonjer HJ, Hop WC, Nelson H et al. Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Arch Surg 2007; 142: 298-303.
24. Quipourt V, Jooste V, Cottet V, Faivre J, Bouvier AM. Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study. J Am Geriatr Soc 2011; 59: 694-8.
25. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16: 1582-7.
26. Aschele C, Bergamo F, Lonardi S. Chemotherapy for operable and advanced colorectal cancer. Cancer Treat Rev 2009; 35: 509-16.
27. Sargent DJ, Goldberg RM, Jacobson SD et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001; 345: 1091-7.
28. Dekker JW, van den Broek CB, Bastiaannet E, van de Geest LG, Tollenaar RA, Liefers GJ. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol 2011; 18: 1533-9.
29. Kahn KL, Adams JL, Weeks JC et al. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 2010; 303: 1037-45.